1254102-12-9

Basic information

• Product Name: (R)-5-(2-azido-1-hydroxyethyl)-8-(benzyloxy)quinolin-2(1H)-one
• Synonyms: (R)-5-(2-azido-1-hydroxyethyl)-8-(benzyloxy)quinolin-2(1H)-one
• CAS NO: 1254102-12-9
• Molecular Weight: 336.35
• Mol File: 1254102-12-9.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: (R)-5-(2-azido-1-hydroxyethyl)-8-(benzyloxy)quinolin-2(1H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-5-(2-azido-1-hydroxyethyl)-8-(benzyloxy)quinolin-2(1H)-one(1254102-12-9)
• EPA Substance Registry System: (R)-5-(2-azido-1-hydroxyethyl)-8-(benzyloxy)quinolin-2(1H)-one(1254102-12-9)

Safety Data

• Hazardous Substances Data: 1254102-12-9(Hazardous Substances Data)

Upstream product

• 100331-89-3 8-benzyloxy-5-(2-bromoacetyl)-1H-quinolin-2-one 
• 93609-84-8 5-acetyl-8-benzyloxy-1H-quinolin-2-one 
• 62978-73-8 5-acetyl-8-hydroxy-2(1H)-quinolinone 
• 15450-72-3 2-oxo-1,2-dihydroquinolin-8-yl acetate 
• 148-24-3 8-quinolinol 
• 1127-45-3 8-Hydroxyquinoline-N-oxide 
• 948893-91-2 (R)-5-(2-azido-1-((tert-butyldimethylsilyl)oxy)ethyl)-8-(benzyloxy)quinolin-2(1H)-one 
• 530084-74-3 (R)-8-(benzyloxy)-5-(2-bromo-1-((tert-butyldimethylsilyl)oxy)ethyl)quinolin-2(1H)-one 
• 530084-79-8 8-(benzyloxy)-5-[(1R)-2-bromo-1-hydroxyethyl]quinolin-2(1H)-one 

Downstream Products

• 1254097-58-9 4-({[5-(2-{[4-({[(2R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl]amino}methyl)phenyl]carbamoyl}ethyl)-2-phenylphenyl]carbamoyl}oxy)-1,1-dimethylpiperidin-1-ium trifluoroacetate 
• 1254098-73-1 4-[({5-[(8-{[(2R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl]amino}octyl)oxy]-2-phenylphenyl}carbamoyl)oxy]-1,1-dimethylpiperidin-1-ium trifluoroacetate 
• 774222-23-0 5-(R)-(2-amino-1-hydroxy-ethyl)-8-phenylmethoxy-(1H)-quinolin-2-one 

Relevant articles and documents

QUATERNARY AMMONIUM SALT COMPOUNDS

[Problem] The object of the present invention is to provide a novel compound having 132 adrenergic receptor agonist activity and muscarinic receptor antagonist activity. [Means for Solving the Problem] The present invention is a quaternary ammonium salt compounds represented by formula (I), or a pharmaceutically acceptable salt thereof, with superior β32 adrenergic receptor agonist activity and muscarinic receptor antagonist activity.

BI-FUNCTIONAL PYRAZOLOPYRIDINE COMPOUNDS

This invention provides compounds of the formula: wherein X is wherein R1 and R2 together with the phenyl to which they are bound may form a bicyclic, fused heterocyclic ring and all other variables are as defined herein, their use in pulmonary inflammation or bronchoconstriction therapy and compositions comprising and processes for preparing the same are provided.